Performance
Trailing returns
| 1 day | +0.58% |
| |||
| 1 week | +1.06% |
| |||
| 4 week | +6.61% |
| |||
| 3 month | +9.43% |
| |||
| YTD | +14.12% |
| |||
| 1 year | +35.55% |
| |||
| 3 years* | +18.05% |
| |||
| 5 years* | +2.25% |
| |||
| *annualized | |||||
| Best 3 month return | +22.54% | |
| Worst 3 month return | -31.74% |
Morningstar statistics
Morningstar category: Foreign Large Growth
| Return | Risk | Rating | |
| 3 years | High | Below Average |
|
| 5 years | High | Below Average |
|
| 10 years | Average | Low |
|
| Overall | High | Below Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 2.32B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.59% | |
| Management fee | - | |
| Fund family | GMO |
Asset allocation
| Cash | 3.55% | |
| Stocks | 96.31% | |
| Bonds | 0.00% | |
| Other | 0.15% |
Purchase information
| Initial | $125,000,000 |
27.56-0.17(-0.61%)
May 22, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks high total return. The fund's manager seeks to achieve the fund's investment objective by investing primarily in a portfolio of equity securities that the Manager believes will provide a higher return than the MSCI EAFE Growth Index. It normally invests directly and indirectly at least 80% of its assets in equity investments (see "Name Policies").
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
David Cowan (Started: Sep 11, 2012)
Thomas Hancock (Started: Nov 30, 2001)
David Cowan (Started: Sep 11, 2012)
Thomas Hancock (Started: Nov 30, 2001)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 6.08 | 5.10 | 3.08 | 1.88 | |
| Beta* | 0.77 | 0.87 | 0.86 | 0.87 | |
| Mean annual return | 1.74 | 1.09 | 0.39 | 0.94 | |
| R-squared* | 97.92 | 95.08 | 94.13 | 92.96 | |
| Standard deviation | 12.67 | 17.42 | 20.45 | 16.50 | |
| Sharpe ratio | 1.64 | 0.74 | 0.22 | 0.58 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Future Contract On Dax Index Future Mar13 /Eur/ | 4.11% | |
| Roche Holding AG (RHHVF) | 3.03% | |
| Nestle SA (NSRGF) | 2.61% | |
| Diageo PLC (DGE) | 2.53% | |
| Novo Nordisk A/S (NONOF) | 2.44% | |
| British American Tobacco PLC (BATS) | 2.40% | |
| Future Contract On S&P/Tsx 60 Ix Fut Mar13 /Cad/ | 2.39% | |
| GMO US Treasury | 2.11% | |
| Rio Tinto PLC (RTPPF) | 1.86% | |
| Bayer AG (BAYN) | 1.82% |